10/26/2026
Korean aesthetics is getting attention. The research deserves a closer look. 👀
For providers exploring another wrinkle-relaxing option, here’s one clinical finding worth knowing:
In a randomized, double-blind, placebo-controlled Phase 3 study of 355 adults, 64.7% of treated participants met the combined patient-and-investigator response criteria at four weeks, compared with 0% receiving placebo.*
This is what I’m encouraging you to do: evaluate the evidence, understand the product’s indications and risks, and consider how it fits your patients and practice.
Curious about the option I’ve been introducing? Message me “KOREAN” to connect.
*Response required improvement of at least two grades AND a rating of none or mild for frown lines at maximum frown by both the patient and investigator. Results apply to the specific formulation studied; they do not establish superiority over other toxins. Prescription neurotoxins carry risks, including a boxed warning for distant spread of toxin effects.
Science source: Aesthetic Surgery Journal, 2022;42(6):677–688.
https://pubmed.ncbi.nlm.nih.gov/35092418/
CandiConsultsBeauty.com